Is Avid Bioservices Stock a Good Investment?
Avid Bioservices Investment Advice | CDMO |
- Examine Avid Bioservices' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Avid Bioservices' leadership team and their track record. Good management can help Avid Bioservices navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Avid Bioservices' business and its evolving consumer preferences.
- Compare Avid Bioservices' performance and market position to its competitors. Analyze how Avid Bioservices is positioned in terms of product offerings, innovation, and market share.
- Check if Avid Bioservices pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Avid Bioservices' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Avid Bioservices stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Avid Bioservices is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Avid Bioservices Stock
Researching Avid Bioservices' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.29. Avid Bioservices last dividend was issued on the 10th of July 2017. The entity had 1:7 split on the 10th of July 2017.
To determine if Avid Bioservices is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Avid Bioservices' research are outlined below:
| Avid Bioservices had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 139.91 M. Net Loss for the year was (140.75 M) with profit before overhead, payroll, taxes, and interest of 31.48 M. | |
| Avid Bioservices has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: BioHarvest Sciences Inc Q3 2024 Earnings Call Highlights Record Revenue Growth and ... |
Avid Bioservices Quarterly Accounts Payable |
|
Avid Bioservices uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Avid Bioservices. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Avid Bioservices' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 19th of June 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 19th of June 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 30th of April 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Avid Bioservices' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Avid Bioservices' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-06-27 | 2019-04-30 | -0.03 | -0.02 | 0.01 | 33 | ||
2022-09-06 | 2022-07-31 | 0.04 | 0.02 | -0.02 | 50 | ||
2020-03-10 | 2020-01-31 | -0.04 | -0.06 | -0.02 | 50 | ||
2019-12-09 | 2019-10-31 | -0.05 | -0.03 | 0.02 | 40 | ||
2019-03-11 | 2019-01-31 | -0.07 | -0.05 | 0.02 | 28 | ||
2021-12-07 | 2021-10-31 | 0.03 | 0.06 | 0.03 | 100 | ||
2018-12-10 | 2018-10-31 | -0.08 | -0.05 | 0.03 | 37 | ||
2022-12-06 | 2022-10-31 | 0.0175 | -0.02 | -0.0375 | 214 |
Know Avid Bioservices' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Avid Bioservices is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avid Bioservices backward and forwards among themselves. Avid Bioservices' institutional investor refers to the entity that pools money to purchase Avid Bioservices' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Portolan Capital Management, Llc | 2024-06-30 | 1.8 M | Geode Capital Management, Llc | 2024-09-30 | 1.5 M | Emerald Advisers, Llc | 2024-09-30 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.2 M | Citadel Advisors Llc | 2024-09-30 | 1.2 M | Emerald Mutual Fund Advisers Trust | 2024-09-30 | 1.1 M | Point72 (difc) Ltd | 2024-09-30 | 1 M | New York State Common Retirement Fund | 2024-09-30 | 985.9 K | Two Sigma Investments Llc | 2024-09-30 | 827.2 K | Blackrock Inc | 2024-06-30 | 5.1 M | Millennium Management Llc | 2024-06-30 | 5.1 M |
Avid Bioservices' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 788.58 M.Market Cap |
|
Avid Bioservices' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.07) | (0.07) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (2.31) | (2.20) |
Determining Avid Bioservices' profitability involves analyzing its financial statements and using various financial metrics to determine if Avid Bioservices is a good buy. For example, gross profit margin measures Avid Bioservices' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Avid Bioservices' profitability and make more informed investment decisions.
Evaluate Avid Bioservices' management efficiency
Avid Bioservices has return on total asset (ROA) of (0.0305) % which means that it has lost $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1584) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Avid Bioservices' Other Assets are very stable compared to the past year. As of the 28th of November 2024, Net Tangible Assets is likely to grow to about 228.8 M, while Return On Tangible Assets are likely to drop (0.44).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.96 | 0.92 | |
| Tangible Book Value Per Share | 0.96 | 0.92 | |
| Enterprise Value Over EBITDA | (56.78) | (53.94) | |
| Price Book Value Ratio | 7.92 | 5.38 | |
| Enterprise Value Multiple | (56.78) | (53.94) | |
| Price Fair Value | 7.92 | 5.38 | |
| Enterprise Value | 212.3 M | 222.9 M |
Avid Bioservices has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.405 |
Basic technical analysis of Avid Stock
As of the 28th of November, Avid Bioservices shows the Risk Adjusted Performance of 0.0758, downside deviation of 3.07, and Mean Deviation of 2.26. Avid Bioservices technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Avid Bioservices' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avid Bioservices insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avid Bioservices' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avid Bioservices insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avid Bioservices' Outstanding Corporate Bonds
Avid Bioservices issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avid Bioservices uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avid bonds can be classified according to their maturity, which is the date when Avid Bioservices has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| AVNT 7125 01 AUG 30 Corp BondUS05368VAA44 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US05367AAH68 Corp BondUS05367AAH68 | View | |
| AVIAGP 9 01 DEC 28 Corp BondUS05368PAA75 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand Avid Bioservices' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Avid Bioservices' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0758 | |||
| Market Risk Adjusted Performance | 2.12 | |||
| Mean Deviation | 2.26 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.07 | |||
| Coefficient Of Variation | 1129.05 | |||
| Standard Deviation | 3.72 | |||
| Variance | 13.87 | |||
| Information Ratio | 0.0549 | |||
| Jensen Alpha | 0.3023 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0665 | |||
| Treynor Ratio | 2.11 | |||
| Maximum Drawdown | 24.79 | |||
| Value At Risk | (5.04) | |||
| Potential Upside | 5.28 | |||
| Downside Variance | 9.45 | |||
| Semi Variance | 6.45 | |||
| Expected Short fall | (2.56) | |||
| Skewness | 1.66 | |||
| Kurtosis | 7.05 |
| Risk Adjusted Performance | 0.0758 | |||
| Market Risk Adjusted Performance | 2.12 | |||
| Mean Deviation | 2.26 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.07 | |||
| Coefficient Of Variation | 1129.05 | |||
| Standard Deviation | 3.72 | |||
| Variance | 13.87 | |||
| Information Ratio | 0.0549 | |||
| Jensen Alpha | 0.3023 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0665 | |||
| Treynor Ratio | 2.11 | |||
| Maximum Drawdown | 24.79 | |||
| Value At Risk | (5.04) | |||
| Potential Upside | 5.28 | |||
| Downside Variance | 9.45 | |||
| Semi Variance | 6.45 | |||
| Expected Short fall | (2.56) | |||
| Skewness | 1.66 | |||
| Kurtosis | 7.05 |
Consider Avid Bioservices' intraday indicators
Avid Bioservices intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avid Bioservices stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 17274.49 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 12.35 | |||
| Day Typical Price | 12.35 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.02 |
Avid Bioservices Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 15th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 28th of August 2024 Other Reports | ViewVerify |
Avid Stock media impact
Far too much social signal, news, headlines, and media speculation about Avid Bioservices that are available to investors today. That information is available publicly through Avid media outlets and privately through word of mouth or via Avid internal channels. However, regardless of the origin, that massive amount of Avid data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avid Bioservices news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avid Bioservices relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avid Bioservices' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avid Bioservices alpha.
Avid Bioservices Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Avid Bioservices can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Avid Bioservices Corporate Management
| Mark JD | General VP | Profile | |
| Daniel Hart | Chief Officer | Profile | |
| Oksana Lukash | Vice People | Profile | |
| Prof Brekken | Medical Advisor | Profile | |
| Harold MD | Medical Advisor | Profile | |
| Prof Schroit | Medical Advisor | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (2.29) | Revenue Per Share 2.245 | Quarterly Revenue Growth 0.065 | Return On Assets (0.03) |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Avid Bioservices' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.